JSK THERAPEUTICS INC.

Company Information
Address 85 FORT DOUGLAS BLVD
SALT LAKE CITY, UT, 84113-5045


Information

DUNS: 957099869

# of Employees: 1


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Clinical Development of JS-K for the Treatment of Cancer

    Amount: $999,183.00

    PROJECT DESCRIPTION JSK Therapeutics JSKT Direct to Phase II Application Nitric oxide NO is a potentially powerful therapy against cancer Spontaneous NO generating drugs cannot be used to treat ...

    SBIRPhase II2017Department of Health and Human Services National Institutes of Health
  2. Preclinical Development of JS-K, a Novel NO-Generating Prodrug for Cancer

    Amount: $927,566.00

    DESCRIPTION (provided by applicant): Despite notable achievements over the past two decades, cancer remains a challenging 21st century epidemic demanding new, more effective drugs. Nitric oxide (NO) ...

    SBIRPhase II2012Department of Health and Human Services
  3. Preclinical Development of JS-K, a Novel NO-Generating Prodrug for Cancer

    Amount: $119,742.00

    DESCRIPTION (provided by applicant): Despite notable achievements over the past two decades, cancer remains a challenging 21st century epidemic demanding new, more effective drugs. Nitric oxide (NO) ...

    SBIRPhase I2010Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government